Equity Research Report: Emergent Biosolutions 3Q17

Download the Report in PDF: EBS Report  Download the Valuation in Excel: Emerging Biosolutions Valuation Emergent Biosolutions Inc.: 3Q17 Recommendation: BUY Target Price                                        : $49.86 Closing Price                                      : $40.86 Upside (Downside) Potential             : 22.0% Company Profile Emergent BioSolutions Inc. develops, manufactures, and commercializes immunobiotics such as vaccines and immune globulins that assist the body’s immuneContinue reading “Equity Research Report: Emergent Biosolutions 3Q17”